インスリンペンの世界市場 (2023-2030年)：タイプ (第一世代ペン・第二世代ペン)・使用法 (プレフィルドペン・再利用可能ペン) 別の規模・シェア・成長分析・予測

インスリンペンの市場規模は、2021年の10億9,000万米ドル、2022年の11億6,000万米ドルから、予測期間中は6.26%のCAGRで推移し、2030年には18億8,000万米ドルの規模に成長すると予測されています。

世界のインスリンペン市場は、糖尿病の有病率の増加と、便利でユーザーフレンドリーなインスリンの送達方法としてのインスリンペンの採用の増加により、近年大きな成長を示しています。インスリンペンには、使いやすさ、正確な投与、携帯性などの利点があり、糖尿病患者に好まれる選択肢となっています。この市場を牽引しているのは、世界の糖尿病人口の増加、糖尿病管理におけるインスリンペンのメリットに関する特に新興諸国での認識の高まりです。さらに、技術の進歩により、メモリー機能、Bluetooth接続、データ追跡および分析用のデジタルプラットフォームとの互換性などの機能を備えた革新的なインスリンペンが開発されています。これらの進歩により、患者の利便性が向上し、治療成績が改善したため、さらなる成長が促進されています。一方で、プラスの成長軌道にもかかわらず、世界のインスリンペン市場はいくつかの課題に直面しています。

一部の人は注射針への恐怖症や自己注射に対する抵抗感があり、インスリンペンの受容や使用が制限される可能性があります。注射針に対する不安や恐怖は、コンプライアンスの低下や代替のインスリン投与方法への嗜好を招く可能性があります。また、インスリンペンの製造者は、デバイスの品質、安全性、有効性を確保するために、厳しい規制要件と安全基準を遵守する必要があります。規制と品質管理措置の遵守は、製造プロセスに複雑さとコストを追加する可能性があります。

当レポートでは、世界のインスリンペンの市場を調査し、市場概要、市場への各種影響因子の分析、技術・イノベーションの動向、法規制環境、市場規模の推移・予測、各種区分・地域別の内訳、競合情勢、主要企業のプロファイルなどをまとめています。

目次

• エグゼクティブサマリー
• 調査手法
• 親市場の分析
  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
• 主要な市場洞察
  • 技術分析
  • 価格分析
  • サプライチェーン分析
  • バリューチェーン分析
  • 市場のエコシステム
  • IP分析
  • 貿易分析
  • スタートアップ分析
  • 原材料分析
  • イノベーションマトリックス
  • パイプライン製品の分析
  • マクロ経済指標
  • 主要投資分析
  • 主要な成功要因
  • 競合の程度
  • 市場力学と見通し
    • 市場力学
      • 促進要因
      • 機会
      • 抑制要因
      • 課題
  • 規制状況
  • ポーターの分析
  • 将来のディスラプションに関するSkyquestの特別な洞察
• 世界のインスリンペン市場：タイプ別
  • 市場概要
  • 第一世代ペン
  • 第二世代ペン
• 世界のインスリンペン市場：使用法別
  • 市場概要
  • プレフィルドペン
  • 再利用可能ペン
• 世界のインスリンペン市場：地域別
  • 市場概要
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ
• 競合情勢
  • トップ5社の比較
  • 主要企業の市場での位置付け
  • 主要企業の採用戦略
  • 主要成功戦略
  • 市場における最近の活動
  • 主要企業の市場シェア
• 主要企業プロファイル
  • Novo Nordisk A/S
  • Eli Lilly and Company
  • Sanofi
  • Ypsomed Holding AG
  • BD (Becton, Dickinson and Company)
  • Owen Mumford Ltd
  • Haselmeier AG
  • Medtronic plc
  • Companion Medical, Inc.
  • Biocon Ltd
  • Emperra GmbH E-Health Technologies
  • Bigfoot Biomedical, Inc.
  • Diamesco Co., Ltd.
  • MANNKind Corporation
  • Jiangsu Delfu Medical Device Co., Ltd.
  • Pendiq GmbH
  • Sensile Medical AG
  • Injex Pharma AG
  • Copernicus Sp. z o.o.
  • Wockhardt Ltd

Insulin Pens Market size was valued at USD 1.09 Billion in 2021 and is poised to grow from USD 1.16 Billion in 2022 to USD 1.88 Billion by 2030, at a CAGR of 6.26% during the forecast period (2023-2030).

The global insulin pens market has witnessed significant growth in recent years due to the increasing prevalence of diabetes and the growing adoption of insulin pens as a convenient and user-friendly method of insulin delivery. Insulin pens offer advantages such as ease of use, accurate dosing, and portability, making them a preferred choice for diabetic patients. The market is driven by the rising diabetic population worldwide, especially in developing countries, coupled with the growing awareness about the benefits of insulin pens in managing diabetes. Furthermore, technological advancements have led to the development of innovative insulin pens with features like memory function, Bluetooth connectivity, and compatibility with digital platforms for data tracking and analysis. These advancements have enhanced patient convenience and improved treatment outcomes, thereby driving market growth. Despite the positive growth trajectory, the global insulin pens market faces certain challenges.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Insulin Pens Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Insulin Pens Market Segmental Analysis

The global insulin pens market is segmented on the basis of type, usability, and region. By type, the market is segmented into first generation pens and second-generation pens. By usability, the market is segmented into prefilled pens and reusable pens. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Insulin Pens Market Dynamics

Insulin Pens Market Drivers

Technological Advancements

• Continuous technological advancements in insulin pen devices, such as Bluetooth connectivity, memory functions, and smart insulin pens, enhance patient experience and improve treatment outcomes. These advancements drive market growth by offering additional features and functionalities to users.

Preference for Self-Administration

• Insulin pens allow patients to self-administer insulin, reducing the need for healthcare provider assistance and promoting patient independence in managing their diabetes. The preference for self-administration contributes to the increasing adoption of insulin pens.

Insulin Pens Market Restraints

Needle Phobia and Resistance

• Some individuals may have needle phobia or resistance to self-injection, which can limit the acceptance and use of insulin pens. Needle anxiety or fear of injections may result in reduced compliance and preference for alternative insulin delivery methods.

Regulatory and Safety Considerations

• Insulin pen manufacturers need to comply with strict regulatory requirements and safety standards to ensure the quality, safety, and effectiveness of their devices. Compliance with regulations and quality control measures can add complexity and cost to the manufacturing process.

Market Trends of the Global Insulin Pens Key

• Customization and Personalization: There is a growing demand for insulin pens that cater to individual patient needs and preferences. Manufacturers are offering customizable options such as different color choices, dose settings, and even personalized branding. Customizable insulin pens enhance user engagement and satisfaction.
• Focus on Safety Features: Safety is a crucial aspect of insulin pens, and manufacturers are incorporating various safety features to ensure accurate dosing and minimize the risk of medication errors. Needle safety systems, dose confirmation mechanisms, and audible/visual alerts are among the safety features being introduced in insulin pen devices.

Table of Contents

• Executive Summary
  • Market Overview
  • Wheel of Fortune
• Research Methodology
  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations
• Parent Market Analysis
  • Market Overview
  • Market Size
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
• Key Market Insights
  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition
• Market Dynamics & Outlook
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
  • Regulatory Landscape
  • Porters Analysis
• Competitive rivalry
• Threat of Substitute Products
• Bargaining Power of Buyers
• Threat of New Entrants
• Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
• Political Impact
• Economic Impact
• Social Impact
• Technical Impact
• Environmental Impact
• Legal Impact
• Global Insulin Pens Market by Type
  • Market Overview
  • first generation pens and second-generation pens
• Global Insulin Pens Market by Usability
  • Market Overview
  • prefilled pens and reusable pens
• Global Insulin Pens Market Size by Region
  • Market Overview
  • North America
• USA
• Canada
  • Europe
• Germany
• Spain
• France
• UK
• Rest of Europe
  • Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
  • Latin America
• Brazil
• Rest of Latin America
  • Middle East & Africa (MEA)
• GCC Countries
• South Africa
• Rest of MEA
• Competitive Landscape
  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
• By Development
• By Company
• By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021
• Key Company Profiles
  • Novo Nordisk A/S - Denmark
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Eli Lilly and Company - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Sanofi - France
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Ypsomed Holding AG - Switzerland
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • BD (Becton, Dickinson and Company) - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Owen Mumford Ltd - UK
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Haselmeier AG - Switzerland
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Medtronic plc - Ireland
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Companion Medical, Inc. - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Biocon Ltd - India
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Emperra GmbH E-Health Technologies - Germany
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Bigfoot Biomedical, Inc. - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Diamesco Co., Ltd. - South Korea
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • MANNKind Corporation - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Jiangsu Delfu Medical Device Co., Ltd. - China
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Pendiq GmbH - Germany
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Sensile Medical AG - Switzerland
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Injex Pharma AG - Switzerland
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Copernicus Sp. z o.o. - Poland
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Wockhardt Ltd - India
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments